27 Mar 2020
Study on a small number of cases of COVID-19 in Europe where ISARIC's Clinical Characterisation protocol was used to build a detailed and comprehensive sampling strategy that enabled the illustration of the different courses of the disease and provide relevant criteria regarding the severity of the disease.
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.